These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 27015553

  • 1. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
    Eisch V, Lu X, Gabriel D, Djabali K.
    Oncotarget; 2016 Apr 26; 7(17):24700-18. PubMed ID: 27015553
    [Abstract] [Full Text] [Related]

  • 2. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J, Acín-Perez R, Cabezas-Sánchez P, Osorio FG, Gonzalez-Gómez C, Megias D, Cámara C, López-Otín C, Enríquez JA, Luque-García JL, Andrés V.
    J Proteomics; 2013 Oct 08; 91():466-77. PubMed ID: 23969228
    [Abstract] [Full Text] [Related]

  • 3. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
    Gabriel D, Roedl D, Gordon LB, Djabali K.
    Aging Cell; 2015 Feb 08; 14(1):78-91. PubMed ID: 25510262
    [Abstract] [Full Text] [Related]

  • 4. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells.
    Cao K, Capell BC, Erdos MR, Djabali K, Collins FS.
    Proc Natl Acad Sci U S A; 2007 Mar 20; 104(12):4949-54. PubMed ID: 17360355
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
    Glynn MW, Glover TW.
    Hum Mol Genet; 2005 Oct 15; 14(20):2959-69. PubMed ID: 16126733
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
    Paradisi M, McClintock D, Boguslavsky RL, Pedicelli C, Worman HJ, Djabali K.
    BMC Cell Biol; 2005 Jun 27; 6():27. PubMed ID: 15982412
    [Abstract] [Full Text] [Related]

  • 9. Farnesyltransferase inhibitor treatment restores chromosome territory positions and active chromosome dynamics in Hutchinson-Gilford progeria syndrome cells.
    Mehta IS, Eskiw CH, Arican HD, Kill IR, Bridger JM.
    Genome Biol; 2011 Aug 12; 12(8):R74. PubMed ID: 21838864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype.
    Gabriel D, Gordon LB, Djabali K.
    PLoS One; 2016 Aug 12; 11(12):e0168988. PubMed ID: 28033363
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R, Croke M, Neumann MA, Bedia-Diaz G, Graziano S, Dusso A, Dorsett D, Carlberg C, Gonzalo S.
    Oncotarget; 2016 May 24; 7(21):30018-31. PubMed ID: 27145372
    [Abstract] [Full Text] [Related]

  • 15. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
    Pellegrini C, Columbaro M, Capanni C, D'Apice MR, Cavallo C, Murdocca M, Lattanzi G, Squarzoni S.
    Oncotarget; 2015 Oct 06; 6(30):29914-28. PubMed ID: 26359359
    [Abstract] [Full Text] [Related]

  • 16. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
    Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, Sandoval S, Meta M, Bendale P, Gelb MH, Young SG, Fong LG.
    Proc Natl Acad Sci U S A; 2005 Jul 19; 102(29):10291-6. PubMed ID: 16014412
    [Abstract] [Full Text] [Related]

  • 17. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
    Chojnowski A, Ong PF, Wong ES, Lim JS, Mutalif RA, Navasankari R, Dutta B, Yang H, Liow YY, Sze SK, Boudier T, Wright GD, Colman A, Burke B, Stewart CL, Dreesen O.
    Elife; 2015 Aug 27; 4():. PubMed ID: 26312502
    [Abstract] [Full Text] [Related]

  • 18. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
    Chang W, Wang Y, Luxton GWG, Östlund C, Worman HJ, Gundersen GG.
    Proc Natl Acad Sci U S A; 2019 Feb 26; 116(9):3578-3583. PubMed ID: 30808750
    [Abstract] [Full Text] [Related]

  • 19. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
    Chen X, Yao H, Andrés V, Bergo MO, Kashif M.
    Basic Clin Pharmacol Toxicol; 2022 Oct 26; 131(4):217-223. PubMed ID: 35790078
    [Abstract] [Full Text] [Related]

  • 20. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
    Wheaton K, Campuzano D, Ma W, Sheinis M, Ho B, Brown GW, Benchimol S.
    Mol Cell Biol; 2017 Jul 15; 37(14):. PubMed ID: 28483909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.